Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) G. Gamba,N. Montani,A. Trinchero,A. Pecci, G. P. Bertolino, F. LodoHAEMOPHILIA（2010）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
